GDTC   $2.22  3.74% Market Closed

CytoMed Therapeutics Ltd
Total Cash 6.82M
totalCashPerShare 0.591
EBITDA -3.12M
Total Debt 428.29K
quickRatio 19.199
currentRatio 21.534
Total Revenue 447.69K
debtToEquity 4.215
Revenue/Share 0.039
ROA -0.17438
ROE -0.26262
grossProfits
freeCashflow -2.59M
operatingCashflow -2.56M
earningsGrowth
revenueGrowth -0.211
grossMargins 1.00036
ebitdaMargins 0.0
operatingMargins -7.3597302
profitMargins 0.0
enterpriseValue 17.61M
forwardPE -13.866666
floatShares 3.55M
sharesOutstanding 11.54M
sharesShort 118.90K
sharesShortPriorMonth 125.59K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.69%
heldPercentInstitutions 0.00%
Short Ratio help_outline 40.28%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 0.881
Price To Book help_outline 2.36
earningsQuarterlyGrowth
netIncomeToCommon -3.06M
trailingEps -0.22%
forwardEps -0.15%
enterpriseToEbitda -5.64
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 1
lastUpdated Oct. 17, 2024, 12:11 p.m.